Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00ZWU
|
|||
Former ID |
DNC008452
|
|||
Drug Name |
4-butyl-N-(quinolin-3-yl)benzamide
|
|||
Synonyms |
CHEMBL259385; 4-butyl-N-(quinolin-3-yl)benzamide; AC1LXX0M; Oprea1_455948; SCHEMBL846651; 4-butyl-N-quinolin-3-ylbenzamide; MolPort-002-564-310; ZINC2228626; STL329914; BDBM50376281; AKOS022106211; MCULE-9844265532; ST020606; (4-butylphenyl)-N-(3-quinolyl)carboxamide; SR-01000396347
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C20H20N2O
|
|||
Canonical SMILES |
CCCCC1=CC=C(C=C1)C(=O)NC2=CC3=CC=CC=C3N=C2
|
|||
InChI |
1S/C20H20N2O/c1-2-3-6-15-9-11-16(12-10-15)20(23)22-18-13-17-7-4-5-8-19(17)21-14-18/h4-5,7-14H,2-3,6H2,1H3,(H,22,23)
|
|||
InChIKey |
LEGBMUNFZPMJOG-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Transient receptor potential cation channel V1 (TRPV1) | Target Info | Inhibitor | [1] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Inflammatory mediator regulation of TRP channels | ||||
NetPath Pathway | IL2 Signaling Pathway | |||
Pathway Interaction Database | Trk receptor signaling mediated by the MAPK pathway | |||
Trk receptor signaling mediated by PI3K and PLC-gamma | ||||
Reactome | TRP channels |
References | Top | |||
---|---|---|---|---|
REF 1 | N-pyridin-3-yl- and N-quinolin-3-yl-benzamides: modulators of human vanilloid receptor 1 (TRPV1). Bioorg Med Chem Lett. 2008 Apr 15;18(8):2730-4. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.